Probiotics to prevent Clostridium difficile infection in patients receiving antibiotics

Goldenberg, JZ; Mertz, D; Johnston, BC

Probiotics to prevent Clostridium difficile infection in patients receiving antibiotics

Goldenberg, JZ Mertz, D Johnston, BC

Permalink

Publication Type:: Journal Article
Citation:: JAMA - Journal of the American Medical Association, 2018, 320 (5), pp. 499 - 500
Issue Date:: 2018-08-07

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published VersionAdobe PDF (133.78 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Goldenberg, JZ	en_US
dc.contributor.author	Mertz, D	en_US
dc.contributor.author	Johnston, BC	en_US
dc.date.issued	2018-08-07	en_US
dc.identifier.citation	JAMA - Journal of the American Medical Association, 2018, 320 (5), pp. 499 - 500	en_US
dc.identifier.issn	0098-7484	en_US
dc.identifier.uri	http://hdl.handle.net/10453/131431
dc.description.abstract	© 2018 American Medical Association. All rights reserved. CLINICAL QUESTION In adults and children prescribed antibiotics, is co-administration of a probiotic associated with a lower risk of symptomatic Clostridium difficile infection without an increase in adverse events? BOTTOM LINE Moderate-quality evidence suggests that probiotics are associated with a lower risk of C difficile infection and very low–quality evidence suggests that probiotics are associated with fewer adverse events vs placebo or no treatment.	en_US
dc.relation.ispartof	JAMA - Journal of the American Medical Association	en_US
dc.relation.isbasedon	10.1001/jama.2018.9064	en_US
dc.subject.classification	General & Internal Medicine	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Clostridium difficile	en_US
dc.subject.mesh	Clostridium Infections	en_US
dc.subject.mesh	Anti-Bacterial Agents	en_US
dc.subject.mesh	Immunocompromised Host	en_US
dc.subject.mesh	Probiotics	en_US
dc.subject.mesh	Adult	en_US
dc.subject.mesh	Child	en_US
dc.subject.mesh	Review Literature as Topic	en_US
dc.subject.mesh	Practice Guidelines as Topic	en_US
dc.title	Probiotics to prevent Clostridium difficile infection in patients receiving antibiotics	en_US
dc.type	Journal Article
utslib.citation.volume	5	en_US
utslib.citation.volume	320	en_US
utslib.for	1103 Clinical Sciences	en_US
utslib.for	11 Medical and Health Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access
pubs.issue	5	en_US
pubs.publication-status	Published	en_US
pubs.volume	320	en_US

Abstract:

© 2018 American Medical Association. All rights reserved. CLINICAL QUESTION In adults and children prescribed antibiotics, is co-administration of a probiotic associated with a lower risk of symptomatic Clostridium difficile infection without an increase in adverse events? BOTTOM LINE Moderate-quality evidence suggests that probiotics are associated with a lower risk of C difficile infection and very low–quality evidence suggests that probiotics are associated with fewer adverse events vs placebo or no treatment.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/131431